Summary
In Aventis Pharma S.A. v. Novopharm Ltd., 2005 FC 815 (CanLII)(decided June 7, 2005), the Federal Court of Canada considered whether Aventis Pharma would suffer irreparable harm if an injunction prohibiting a generic drug from entering the market was not ...
Aventis Pharma S.A. v. Novopharm Ltd.
PDF, Size: 188 KB
See Also
Injunction Denied Where Expert Testimony Shows Monetary Damages Were Subject to Quantification
In Aventis Pharma S.A. v. Novopharm Ltd., 2005 FC 815 (CanLII)(decided June 7, 2005), the Federal Court of Canada considered whether Aventis Pharma would suffer irreparable harm if an injunction prohibiting a generic drug from entering the market was not ...